Human Immunodeficiency Virus (HIV) Infection - References

SYMPTOMS & TREATMENTS

Citations

  1. Triant VA, et al. (2007). Increased acute myocardial infarction rates and cardiovascular risk factors among patients with HIV disease. Journal of Clinical Endocrinology and Metabolism. Available online: http://jcem.endojournals.org/cgi/rapidpdf/jc.2006-2190v1 (e-pub ahead of print).

  2. Chaturvedi AK, et al. (2007). Elevated risk of lung cancer among people with AIDS. AIDS, 21(2): 207–213.

  3. Centers for Disease Control and Prevention (2009). Cases of HIV infection and AIDS in the United States and dependent areas, 2007. HIV/AIDS Surveillance Report, No. 19. Available online: http://www.cdc.gov/hiv/topics/surveillance/resources/reports/2007report/default.htm.

  4. Violari A, et al. (2008). Early antiretroviral therapy and mortality among HIV-infected infants. New England Journal of Medicine, 359(21): 2233–2244.

  5. U.S. Department of Health and Human Services (2009). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Available online: http://www.aidsinfo.nih.gov/contentfiles/AdultandAdolescentGL.pdf.

  6. Centers for Disease Control and Prevention (2005). Updated U.S. Public Health Services guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis. MMWR, 50(RR-09): 1–17. Available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5409a1.htm.

  7. Centers for Disease Control and Prevention (2005). Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States. Recommendations from the U.S. Department of Health and Human Services. Available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5402a1.htm.

  8. Braithwaite RS, et al. (2008). Influence of alternative thresholds for initiating HIV treatment on quality-adjusted life expectancy: A decision model. Annals of Internal Medicine, 148(3): 178–185.

  9. Hammer, Scott M, et al. (2008). Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society USA Panel. JAMA, 300 (5): 555–570.

  10. U.S. Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents (2011). Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Available online: http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.

  11. U.S. Centers for Disease Control and Prevention (2011). Interim guidance: Preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. MMWR, 60(03): 65–68. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6003a1.htm.

Other Works Consulted

  • Aberg JA, et al. (2009). Primary care guidelines for the management of persons infected with HIV: 2009 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clinical Infectious Diseases, 49(5): 651–681.

  • American College of Obstetricians and Gynecologists (2008). Prenatal and perinatal human immunodeficiency virus testing: Expanded recommendations. ACOG Committee Opinion No. 418. Obstetrics and Gynecology, 112(3): 739–742.

  • Antiretroviral Therapy Cohort Collaboration (2003). Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: Analysis of prospective studies. Lancet, 362(9385): 679–686.

  • Del Rio C, Curran JW (2010). Epidemiology and prevention of acquired immunodeficiency syndrome and human inmmunodeficiency virus infection. In GL Mandell et al., eds., Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 7th ed., vol. 1, pp. 1635–1661. Philadelphia: Churchill Livingstone Elsevier.

  • Eron JJ Jr, Hirsch MS (2008). Antiviral therapy of human immunodeficiency virus infection. In KK Holmes et al., eds., Sexually Transmitted Diseases, 4th ed., pp. 1393–1421. New York: McGraw-Hill.

  • Kitahata MM, et al. (2009). Effect of early versus deferred antiretroviral therapy for HIV on survival. New England Journal of Medicine. Published online April 1, 2009 (doi:10.1056/NEJMoa0807252).

  • Mocroft A, et al. (2003). Decline in AIDS and death rates in the EuroSIDA study: An observational study. Lancet, 362(9377): 22–29.

  • Rerks-Ngarm S, et al. (2009). Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. New England Journal of Medicine, 361(23): 2209–2220.

  • Thompson MA, et al. (2010). Antiretroviral treatment of adult HIV infection: 2010 Recommendations of the International AIDS Society—USA Panel. Journal of the American Medical Society, 304(3): 321–333.

  • U.S. Centers for Disease Control and Prevention (2009). Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR, 58(Early Release): 1–207.

  • World Health Organization (2009). Antiretroviral therapy for HIV infection in adults and adolescents: Rapid advice. Available online: http://www.who.int/hiv/pub/arv/rapid_advice_art.pdf.

  • World Health Organization (2009). HIV and infant feeding, revised principles and recommendations: Rapid advice. Available online: http://whqlibdoc.who.int/publications/2009/9789241598873_eng.pdf.

  • World Health Organization (2009). Use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: Rapid advice. Available online: http://www.who.int/hiv/pub/mtct/rapid_advice_mtct.pdf.

By: Healthwise StaffLast Revised: May 18, 2011
Medical Review: E. Gregory Thompson, MD - Internal Medicine
Peter Shalit, MD, PhD - Internal Medicine

© 1995-2011 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated. This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.

Advertisement
Care Circle

It Seems That You Are Not Logged In...

OR

Join Now

Welcome to Care Circle, an exclusive tool to help you take care of yourself and your loved ones. Here's how it works:

  1. Create profiles for yourself and your loved ones.
  2. Select the topics and conditions that interest each of you.
  3. Get customized news updates, original content, tools, and expert advice for each Care Circle member delivered directly to your personalized homepage.

The information you input is strictly private; you choose who has access to your Care Circle.

How do I add myself or someone else to my care circle?

Click on "Add someone." Fill out the short profile. Choose an avatar. Select the topics and conditions that interest this person from the pulldown menu. You can select as many as you want, but you must choose at least one. Click on "Add Someone" again. You should start getting updates immediately.

How do I save content to my Care Circle?

Click on "Manage My Care Circle." Select the tab of the person for whom you're saving content. Put your cursor over the piece of content that you want to save; a disk icon will appear in the righthand corner. Click on the disk and the piece of content will be moved to a save folder.

How do I add additional topics and conditions for someone in my Care Circle?

Click on "Manage My Care Circle." Select the tab for the person whose preferences you'd like to update. Under "Add More to Follow," select additional topics and conditions.

How do I delete topics and conditions for someone in my Care Circle?

Click on "Manage My Care Circle." Select the tab for the person whose preferences you'd like to update. Under "Follows," scroll over the topic or condition you want to delete. An "X" should appear on the righthand side. Click on the "X" and the topic or condition will be deleted from the list.

See All News

Advertisement